newsfilter
← Latest News
Business Wire·

Esteve Launches INBRIJA® in Germany

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that Esteve Pharmaceuticals GmbH has launched INBRIJA® 33 mg (levodopa inhalation powder, hard capsules) in Germany. INBRIJA is indicated in the EU for the intermittent treatment of episodic motor